SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,857 | -7.2% | 33,100 | +24.3% | 0.00% | – |
| Q2 2023 | $123,778 | -74.3% | 26,619 | -74.5% | 0.00% | -100.0% |
| Q1 2023 | $482,074 | +85.5% | 104,345 | +224.4% | 0.00% | – |
| Q4 2022 | $259,861 | -99.9% | 32,161 | -19.9% | 0.00% | – |
| Q3 2022 | $222,838,000 | +25.9% | 40,151 | +18.2% | 0.00% | – |
| Q2 2022 | $176,932,000 | -18.7% | 33,960 | +28.3% | 0.00% | – |
| Q1 2022 | $217,624,000 | -14.0% | 26,475 | +55.6% | 0.00% | – |
| Q4 2021 | $253,124,000 | +27.4% | 17,011 | +61.8% | 0.00% | – |
| Q3 2021 | $198,609,000 | +136.8% | 10,514 | +133.0% | 0.00% | – |
| Q2 2021 | $83,878,000 | -86.9% | 4,512 | -83.9% | 0.00% | -100.0% |
| Q1 2021 | $638,509,000 | +378.8% | 28,054 | +356.8% | 0.00% | – |
| Q4 2020 | $133,343,000 | +114.5% | 6,142 | -0.7% | 0.00% | – |
| Q3 2020 | $62,179,000 | +866.6% | 6,187 | +646.3% | 0.00% | – |
| Q2 2020 | $6,433,000 | -81.4% | 829 | -75.5% | 0.00% | – |
| Q1 2020 | $34,496,000 | +29.2% | 3,382 | +39.3% | 0.00% | – |
| Q4 2019 | $26,708,000 | +131.2% | 2,428 | +91.0% | 0.00% | – |
| Q3 2019 | $11,553,000 | -14.0% | 1,271 | +7.6% | 0.00% | – |
| Q2 2019 | $13,440,000 | -22.2% | 1,181 | -22.1% | 0.00% | – |
| Q1 2019 | $17,267,000 | – | 1,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |